warnings
Warnings
Best Choice Ultra Fine Mist
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Best Choice Ultra Fine Mist
- Generic name
- OXYMETAZOLINE HYDROCHLORIDE
- Manufacturer
- BEST CHOICE (VALU MERCHANDISERS COMPANY)
- Product type
- HUMAN OTC DRUG
- SPL set ID
- 7d19fdba-35b0-424a-ba11-315521d3256d
- SPL ID
- 94d35f6e-4b12-4763-9ffe-b9f7927708d0
- Version
- 8
- Effective date
- 2026-07-17
- Source export date
- 2026-10-12
- Source partition
- 6
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/b25dad4aaef9c88f0e827394a34fbbd1ce7d71422fa46b5d1e123befad498c1d/drug-label-0006-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 01:46:38
| Harmonized routes |
|---|
| NASAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application number | M012 | openfda.application_number | |
| brand name | Best Choice Ultra Fine Mist | openfda.brand_name | |
| generic name | OXYMETAZOLINE HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | BEST CHOICE (VALU MERCHANDISERS COMPANY) | openfda.manufacturer_name | |
| ndc | package | 63941-726-30 | openfda.package_ndc |
| ndc | product | 63941-726 | openfda.product_ndc |
| ndc11 | package | 63941072630 | derived:openfda.package_ndc |
| rxcui | 1000990 | openfda.rxcui | |
| spl id | 94d35f6e-4b12-4763-9ffe-b9f7927708d0 | id | |
| spl set id | 7d19fdba-35b0-424a-ba11-315521d3256d | set_id | |
| unii | K89MJ0S5VY | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.